Balyasny Asset Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-30,800
| Closed | -$345K | – | 2182 |
|
|
2017
Q3 | $345K | Buy |
+30,800
| New | +$345K | ﹤0.01% | 1272 |
|
|
2017
Q2 | – | Sell |
-17,575
| Closed | -$172K | – | 1666 |
|
|
2017
Q1 | $172K | Sell |
17,575
-1,130
| -6% | -$11.1K | ﹤0.01% | 1319 |
|
|
2016
Q4 | $202K | Buy |
18,705
+2,630
| +16% | +$28.4K | ﹤0.01% | 1089 |
|
|
2016
Q3 | $165K | Buy |
16,075
+4,900
| +44% | +$50.3K | ﹤0.01% | 845 |
|
|
2016
Q2 | $146K | Sell |
11,175
-5,210
| -32% | -$68.1K | ﹤0.01% | 899 |
|
|
2016
Q1 | $180K | Buy |
+16,385
| New | +$180K | ﹤0.01% | 941 |
|